CardioLogic Innovations
Lung Fluid Level Monitoring
Company Overview
Snapshot
Founded in June 2012 by Shay Faitelzon, CardioLogic Innovations operated with 1–10 employees. The company developed a patented platform technology for monitoring lung fluid levels, a significant milestone in its early development.
Business overview
CardioLogic Innovations developed a patented platform technology focused on precisely monitoring fluid levels in each lung. This technology aimed to prevent acute heart failure hospitalizations by providing non-invasive devices for inpatient, outpatient, and home use. The company also offered an integrative solution designed to enhance existing implantable cardiac resynchronization therapy and implantable cardioverter defibrillator devices, operating within the Health Tech & Life Sciences sector, specifically in medical devices and digital healthcare for patient remote monitoring.
Company Intelligence Q&A
- What is CardioLogic Innovations' primary focus?
- CardioLogic Innovations developed a patented platform technology for precise monitoring of fluid levels in each lung, primarily to prevent acute heart failure hospitalizations.
- When was CardioLogic Innovations founded?
- CardioLogic Innovations was founded in June 2012.
- Who is the founder of CardioLogic Innovations?
- Shay Faitelzon is the co-founder of CardioLogic Innovations.
- What is the status of CardioLogic Innovations?
- CardioLogic Innovations ceased to operate in April 2018.
- What type of products did CardioLogic Innovations develop?
- CardioLogic Innovations developed non-invasive devices for inpatient, outpatient, and home use, as well as an integrative solution for enhancing implantable cardiac devices.